Drug Shortage Report for APO-DEXLANSOPRAZOLE
| Report ID | 230579 |
| Drug Identification Number | 02529025 |
| Brand name | APO-DEXLANSOPRAZOLE |
| Common or Proper name | DEXLANSOPRAZOLE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXLANSOPRAZOLE |
| Strength(s) | 60MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | NASOGASTRIC ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 BTL |
| ATC code | A02BC |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-06-14 |
| Estimated end date | 2024-12-13 |
| Actual end date | 2024-12-05 |
| Shortage status | Resolved |
| Updated date | 2024-12-06 |
| Company comments | Product available via monthly manufacturing, allocation required due to increased demand. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v9 | 2024-12-06 | French | Compare |
| v8 | 2024-12-06 | English | Compare |
| v7 | 2024-11-14 | French | Compare |
| v6 | 2024-11-14 | English | Compare |
| v5 | 2024-08-15 | French | Compare |
| v4 | 2024-08-15 | English | Compare |
| v3 | 2024-06-15 | English | Compare |
| v2 | 2024-06-14 | French | Compare |
| v1 | 2024-06-14 | English | Compare |
Showing 1 to 9 of 9